5-23509053-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020227.4(PRDM9):āc.20A>Gā(p.Gln7Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,614,114 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020227.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRDM9 | NM_020227.4 | c.20A>G | p.Gln7Arg | missense_variant | 2/11 | ENST00000296682.4 | |
PRDM9 | NM_001376900.1 | c.20A>G | p.Gln7Arg | missense_variant | 2/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRDM9 | ENST00000296682.4 | c.20A>G | p.Gln7Arg | missense_variant | 2/11 | 1 | NM_020227.4 | P1 | |
PRDM9 | ENST00000502755.6 | c.20A>G | p.Gln7Arg | missense_variant | 2/11 | 4 | |||
PRDM9 | ENST00000635252.1 | c.17-867A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152182Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249542Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135400
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461814Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727208
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152300Hom.: 1 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.20A>G (p.Q7R) alteration is located in exon 2 (coding exon 1) of the PRDM9 gene. This alteration results from a A to G substitution at nucleotide position 20, causing the glutamine (Q) at amino acid position 7 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at